NIH on tobacco
This article was originally published in The Tan Sheet
Executive Summary
Effective provider-reimbursement policies for tobacco control need to be developed to make progress towards the public health benefits of quitting tobacco use, according to a 14-member NIH State-of-the-Science conference panel on tobacco use. The panel, which met June 12-14, pointed out that tobacco use remains the U.S.'s leading preventable cause of premature death with more than 440,000 American deaths per year as a result of a tobacco-related disease. Panelists also found that interventions and treatments aimed at helping smokers quit such as nicotine replacement therapy, telephone quitlines and counseling, all were effective individually, but were even more successful when combined...
You may also be interested in...
US FDA Gene Therapy Accelerated Approval Guidance Will Describe ‘Buckets’ Of Use Scenarios
Forthcoming guidance is expected to describe areas of “low-hanging fruit” and those that are more challenging for use of the expedited pathway, Center for Biologics Evaluation and Research Director Peter Marks said.
FTC Early Findings In PBM Investigation Coming By Mid-Summer, Chair Kahn Says
The agency is also poised to announce another development in its scrutiny of the drug patents listed in the FDA’s Orange Book.
ImmunityBio Will Aim Anktiva At Large Share Of Bladder Cancer Market
Execs Richard Adcock and Patrick Soon-Shiong told Scrip the company sees an addressable US population of about 20,000 and is aiming for ease of physician adoption.